Hinge Health Projects Q2 Revenue of $200M-$202M
Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Health Tech Stocks · Healthcare
Sentiment
Neutral
Importance
8
Price
$64.74
Mkt Cap
$4.858B
52W Low
$30.08
52W High
$66.55
52W Position
115% above low
Off High
2.7% below high
Rel. Volume
1.3× avg
Market data snapshot near publication time
HNGE has more than doubled off its 52-week low of $30.08.
Summary
Hinge Health projects Q2 revenue to be between $200 million and $202 million. This guidance follows the company's strong Q1 2026 results reported on May 5th, which saw revenue of $182.31 million and a raised full-year outlook. The projected sequential growth from Q1 to Q2 is a key indicator for traders assessing the company's ongoing performance and momentum.
At the time of this announcement, HNGE was trading at $64.74 on NYSE in the Technology sector, with a market capitalization of approximately $4.9B. The 52-week trading range was $30.08 to $66.55. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.
Price Chart
HNGE - Latest Insights
HNGE
Oct 14, 2026, 5:55 PM EDT
Price at Filing:
$105.00
Real-time Price:
$113.50
Change:
+$8.50 (+8%)
Market Cap:
$9.225B
HNGE
Oct 14, 2026, 5:28 PM EDT
Price at Filing:
$105.00
Real-time Price:
$113.50
Change:
+$8.50 (+8%)
Market Cap:
$9.225B
HNGE
Sep 14, 2026, 4:15 PM EDT
Price at Filing:
$94.00
Real-time Price:
$113.50
Change:
+$19.50 (+21%)
Market Cap:
$9.225B
HNGE
Sep 11, 2026, 4:30 PM EDT
Price at Filing:
$88.59
Real-time Price:
$113.50
Change:
+$24.91 (+28%)
Market Cap:
$9.225B
HNGE
Aug 04, 2026, 6:27 PM EDT
Price at Filing:
$78.74
Real-time Price:
$113.50
Change:
+$34.76 (+44%)
Market Cap:
$9.225B